“SC TEAMS UP WITH OXFORD CENTRE FOR ISLAMIC STUDIES (Bernama via Yahoo! Malaysia News)” plus 3 more |
- SC TEAMS UP WITH OXFORD CENTRE FOR ISLAMIC STUDIES (Bernama via Yahoo! Malaysia News)
- HGS, BioInvent International AB to discover, develop and commercialize therapeutic monoclonal antibodies (News-Medical-Net)
- Chelsea Therapeutics 4Q loss narrows on costs (AP via Yahoo! News)
- RNA Sequencing Studies Provide Insights into Gene Expression in African, European Populations (GenomeWeb News)
SC TEAMS UP WITH OXFORD CENTRE FOR ISLAMIC STUDIES (Bernama via Yahoo! Malaysia News) Posted: 10 Mar 2010 11:46 PM PST KUALA LUMPUR, March 11 (Bernama) -- The Securities Commission Malaysia (SC) and the Oxford Centre for Islamic Studies (OCIS) have teamed up to create an international platform for debate, dialogue and study on contemporary issues and challenges faced in Islamic finance. The inaugural collaboration with the OCIS, will help further facilitate intellectual discourse among Islamic finance experts, Shariah advisers and scholars from around the world, the SC said in a statement here, today. The OCIS is well known for its research and academic excellence. "The collaboration reflects our commitment to building knowledge and encouraging research and discourse in Islamic finance," SC Chairman, Tan Sri Zarinah Anwar said. Towards this end, both sides will jointly host a high-level roundtable and public forum on March 15-16 in Kuala Lumpur, to discuss the way forward for Islamic finance following the global financial crisis. OCIS Director, Dr Farhan Nizami said it had embarked on the study of Islamic finance, in a move to promote a more comprehensive understanding of Islamic culture and civilisation. "The OCIS is dedicated to achieving by academic means, a better understanding of Islam and the needs of Muslim societies. As part of this objective, it is embarking on the study of Islamic finance," he explained. "Given Malaysia's success in the development of Islamic capital markets, the OCIS welcomes the opportunity to work in partnership with the SC in this important area of study," he added. Meanwhile, the topic for the closed-door roundtable is,"Developing a Scientific Methodology on Shariah Governance for Positioning Islamic Finance Globally". The public forum on March 16 will see 300 industry practitioners, regulators and scholars attending. It will discuss the contribution of Islamic finance, post the financial crisis. Raja Dr. Nazrin Shah ibni Sultan Azlan Muhibbuddin Shah, the Regent of Perak, who is also the Financial Ambassador to the Malaysia international Islamic Financial Centre (MIFC), will deliver his keynote address at both events. Zarinah and Nizami will also be speaking.-- BERNAMA SM AS Five Filters featured article: Chilcot Inquiry. Available tools: PDF Newspaper, Full Text RSS, Term Extraction. |
Posted: 11 Mar 2010 12:42 AM PST Human Genome Sciences, Inc. (Nasdaq: HGSI) and BioInvent International AB (OMXS: BINV) today announced that they have entered into a collaboration to discover, develop and commercialize therapeutic monoclonal antibodies that specifically target antigens discovered by HGS.
Under the terms of the agreement, BioInvent will apply its state-of-the art antibody discovery technology to generate and develop monoclonal antibody candidates. The collaboration will initially focus on the development of antibodies in the field of inflammation. HGS and BioInvent will each have the right to participate in development and global commercialization of each antibody candidate, and will share research, development, manufacturing and commercialization costs as well as future revenues. Specific terms were not disclosed. "We continue to make excellent progress in advancing our late-stage products toward commercialization, and at the same time we remain committed to building and advancing our research pipeline to ensure sustainable growth well into the future," said H. Thomas Watkins, President and Chief Executive Officer, HGS. "We look forward to collaborating with BioInvent to apply their proprietary technology to the development of targeted new therapies based on HGS discoveries." Svein Mathisen, Chief Executive Officer of BioInvent, said, "Access to commercially attractive targets to which we can apply our antibody discovery engine is an important part of BioInvent's strategy. We believe this collaborative agreement is a strong and valuable way of building our pipeline of innovative drugs as BioInvent and HGS's research strengths are both complementary and synergistic. We are looking forward to working closely with HGS in what we believe will be a long-term, productive collaboration." SOURCE Human Genome Sciences, Inc. Five Filters featured article: Chilcot Inquiry. Available tools: PDF Newspaper, Full Text RSS, Term Extraction. |
Chelsea Therapeutics 4Q loss narrows on costs (AP via Yahoo! News) Posted: 10 Mar 2010 04:10 PM PST 15 seconds ago 2010-03-11T02:38:45-08:00 Five Filters featured article: Chilcot Inquiry. Available tools: PDF Newspaper, Full Text RSS, Term Extraction. |
Posted: 10 Mar 2010 01:00 PM PST NEW YORK (GenomeWeb News) – Two new high-throughput RNA sequencing studies by independent research groups are offering a glimpse into gene splicing, expression, and regulation patterns in European and Yoruban populations. The papers, which relied on samples collected through the International HapMap Project, appear online in Nature today. In the first of these studies, University of Chicago researchers used the Illumina Genome Analyzer II to sequence complementary DNA libraries from lymphoblastoid cell lines created for 69 Yoruban individuals sampled through the HapMap project. Compared with microarray-based studies of gene expression, RNA-Seq does not rely on probing specific parts of the genome that are thought to be expressed, lead author Joseph Pickrell, a graduate student in University of Chicago geneticist Jonathan Pritchard's lab, told GenomeWeb Daily News. Instead, Pickrell explained, the sequencing approach offers an unbiased look at expression — providing data that can be used to interpret information about genetic variants influencing gene expression and more Their RNA sequencing approach turned up transcripts at more than 4,000 previously unannotated regions, including protein-coding transcripts, alternatively spliced exons, and previously undetected untranslated regions. By incorporating data on millions of SNPs genotyped through the HapMap project, the researchers uncovered 929 genes or potential exons with expression quantitative trait loci, or eQTLs, within 200,000 bases. They found that some 90 percent of SNPs influencing gene expression are located near the affected genes. Their results also suggest that such eQTLs have allele-specific effects on gene expression. "We demonstrate that eQTLs near genes generally act by a mechanism involving allele-specific expression," the researchers wrote, "and that variation that influences the inclusion of an exon is enriched within and near the consensus splice sites." In their subsequent experiments, the team also identified 187 genes that appear to be associated with splicing QTLs, or sQTLs — variants influencing which isoforms get expressed. The team plans to do more extensive studies aimed at determining which individual SNPs affect gene expression and how, Pickrell said. He noted that the genomes of cell lines used in the study have now been sequenced, giving the researchers access to all possible causal SNPs. "Studies of variation in gene expression using microarrays have provided insight into the mechanism of action of loci associated with disease," Pickrell and his co-workers wrote. "[T]he increased sensitivity to detect variation by RNA-Seq will greatly enhance these efforts." Meanwhile, researchers from Switzerland, the UK, and Spain used paired-end sequencing with the Illumina Genome Analyzer II to assess transcriptomes from lymphoblastoid cell lines created from 60 European individuals from the HapMap3 project — work that is providing information on everything from transcript abundance, eQTLs, and allele-specific expression patterns in that population to exon structure and variants influencing alternative splicing. "[RNA-sequencing] allows us to get a really deep resolution of the transcriptome," lead author Stephen Montgomery, a post-doctoral researcher who was formerly at the Wellcome Trust Sanger Institute and is now at the University of Geneva, told GWDN, noting that gene expression appears to be much more complex than previously appreciated. In addition, Montgomery explained, comparisons between his group's data and eQTLs for the top 500 genes from the Yoruban population study suggest that some 33 percent of the signals overlapped, suggesting many of the same SNPs affecting gene expression in the European group are shared in the African individuals tested. Although researchers also expect to see some population- and tissue-specific gene expression patterns, Montgomery added, this overlap between eQTLs in data from distinct populations generated by independent research groups is encouraging. "That was actually a really good replication," he said. Such gene expression data may eventually inform genome-wide association studies of disease, Montgomery explained, since some of the SNPs coming out of these GWAS fall in non-coding regions of the genome and may exert an effect by altering gene expression. He and his co-workers at the University of Geneva are currently following up on the study by doing cellular phenotype studies looking at how genetic patterns influence cellular features. "As sequencing technologies continue to increase the depth and breadth of the interrogation of the genome and the transcriptome, it is anticipated that our understanding of finer scale cellular processes will become more detailed and robust," the researchers concluded. Five Filters featured article: Chilcot Inquiry. Available tools: PDF Newspaper, Full Text RSS, Term Extraction. |
You are subscribed to email updates from Yahoo! News Search Results for International Studies To stop receiving these emails, you may unsubscribe now. | Email delivery powered by Google |
Google Inc., 20 West Kinzie, Chicago IL USA 60610 |
No comments:
Post a Comment